TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer

July 2, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search